Ischemic stroke is the second leading cause of death worldwide, yet there are few therapeutic approaches available to treat this condition and those that exist, such as thrombolytic tissue plasminogen activator (tPA), are limited by a narrow therapeutic window [48]. Here, PLAT is linked to ischemic stroke.